ID MK13_BOVIN Reviewed; 366 AA. AC Q3T0N5; DT 25-JUL-2006, integrated into UniProtKB/Swiss-Prot. DT 11-OCT-2005, sequence version 1. DT 08-NOV-2023, entry version 106. DE RecName: Full=Mitogen-activated protein kinase 13; DE Short=MAP kinase 13; DE Short=MAPK 13; DE EC=2.7.11.24; GN Name=MAPK13; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Crossbred X Angus; TISSUE=Ileum; RG NIH - Mammalian Gene Collection (MGC) project; RL Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Serine/threonine kinase which acts as an essential component CC of the MAP kinase signal transduction pathway. MAPK13 is one of the CC four p38 MAPKs which play an important role in the cascades of cellular CC responses evoked by extracellular stimuli such as pro-inflammatory CC cytokines or physical stress leading to direct activation of CC transcription factors such as ELK1 and ATF2. Accordingly, p38 MAPKs CC phosphorylate a broad range of proteins and it has been estimated that CC they may have approximately 200 to 300 substrates each. MAPK13 is one CC of the less studied p38 MAPK isoforms. Some of the targets are CC downstream kinases such as MAPKAPK2, which are activated through CC phosphorylation and further phosphorylate additional targets. Plays a CC role in the regulation of protein translation by phosphorylating and CC inactivating EEF2K. Involved in cytoskeletal remodeling through CC phosphorylation of MAPT and STMN1. Mediates UV irradiation induced up- CC regulation of the gene expression of CXCL14. Plays an important role in CC the regulation of epidermal keratinocyte differentiation, apoptosis and CC skin tumor development. Phosphorylates the transcriptional activator CC MYB in response to stress which leads to rapid MYB degradation via a CC proteasome-dependent pathway. MAPK13 also phosphorylates and down- CC regulates PRKD1 during regulation of insulin secretion in pancreatic CC beta cells (By similarity). {ECO:0000250}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl- CC [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA- CC COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.24; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L- CC threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, CC Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; CC EC=2.7.11.24; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250}; CC -!- ACTIVITY REGULATION: Activated by phosphorylation on threonine and CC tyrosine by dual specificity kinases, MAP2K3/MKK3 MAP2K6/MKK6, CC MAP2K4/MKK4 and MAP2K7/MKK7. Activation by ultraviolet radiation, CC hyperosmotic shock, anisomycin or by TNF-alpha is mediated by CC MAP2K3/MKK3. Inhibited by dual specificity phosphatase DUSP1 (By CC similarity). {ECO:0000250}. CC -!- SUBUNIT: Interacts with MAPK8IP2. {ECO:0000250}. CC -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues CC whose phosphorylation activates the MAP kinases. CC -!- PTM: Dually phosphorylated on Thr-180 and Tyr-182 by MAP2K3/MKK3, CC MAP2K4/MKK4, MAP2K6/MKK6 and MAP2K7/MKK7, which activates the enzyme. CC Dephosphorylated by dual specificity phosphatase DUSP1 (By similarity). CC {ECO:0000250}. CC -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr CC protein kinase family. MAP kinase subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BC102319; AAI02320.1; -; mRNA. DR AlphaFoldDB; Q3T0N5; -. DR SMR; Q3T0N5; -. DR STRING; 9913.ENSBTAP00000013198; -. DR PaxDb; 9913-ENSBTAP00000013198; -. DR eggNOG; KOG0660; Eukaryota. DR InParanoid; Q3T0N5; -. DR Proteomes; UP000009136; Unplaced. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0004707; F:MAP kinase activity; IEA:UniProtKB-EC. DR GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA. DR GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central. DR GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW. DR GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central. DR GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW. DR CDD; cd07879; STKc_p38delta; 1. DR Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1. DR InterPro; IPR011009; Kinase-like_dom_sf. DR InterPro; IPR003527; MAP_kinase_CS. DR InterPro; IPR038785; MAPK13. DR InterPro; IPR008352; MAPK_p38-like. DR InterPro; IPR000719; Prot_kinase_dom. DR InterPro; IPR017441; Protein_kinase_ATP_BS. DR PANTHER; PTHR24055; MITOGEN-ACTIVATED PROTEIN KINASE; 1. DR PANTHER; PTHR24055:SF107; MITOGEN-ACTIVATED PROTEIN KINASE 13; 1. DR Pfam; PF00069; Pkinase; 1. DR PRINTS; PR01773; P38MAPKINASE. DR SMART; SM00220; S_TKc; 1. DR SUPFAM; SSF56112; Protein kinase-like (PK-like); 1. DR PROSITE; PS01351; MAPK; 1. DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1. DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1. PE 2: Evidence at transcript level; KW ATP-binding; Cell cycle; Kinase; Nucleotide-binding; Phosphoprotein; KW Reference proteome; Serine/threonine-protein kinase; Stress response; KW Transcription; Transcription regulation; Transferase. FT CHAIN 1..366 FT /note="Mitogen-activated protein kinase 13" FT /id="PRO_0000246181" FT DOMAIN 25..308 FT /note="Protein kinase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT MOTIF 180..182 FT /note="TXY" FT ACT_SITE 150 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT BINDING 31..39 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT BINDING 54 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT MOD_RES 47 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O15264" FT MOD_RES 180 FT /note="Phosphothreonine; by MAP2K3, MAP2K4, MAP2K6 and FT MAP2K7" FT /evidence="ECO:0000250|UniProtKB:O15264" FT MOD_RES 182 FT /note="Phosphotyrosine; by MAP2K3, MAP2K4, MAP2K6 and FT MAP2K7" FT /evidence="ECO:0000250|UniProtKB:O15264" FT MOD_RES 350 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O15264" SQ SEQUENCE 366 AA; 42229 MW; C35CF0064C4BE83E CRC64; MSFTRKKGFY KQDVNKTAWE LPKTYVSLTH IGSGAYGSVC SAIDKRSGEK VAIKKLSRPF QSEIFAKRAY RELLLLKHMQ HENVIGLLDV FTPASSLRNF HDFYLVMPFM QTDLQKIMGM EFSEDKIQYL VYQMLKGLKY IHSAGVVHRD LKPGNLAVNE DCELKILDFG LARHTDVEMT GYVVTRWYRA PEVILSWMHY NQTVDIWSVG CIMAEMLTGK TLFKGKDYLD QLTQILKVTG VPGAEFVQKL NDKAAKSYIQ SLPQSPKKDF SQLFPRASPQ ATDLLEKMLE LDVDKRLTAS QALAHPFFEP FRDPEEETEA QQPLEDSLER EKLIVDEWKQ HIYKEIVNFS PIARKDSRRR SGMKLQ //